High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments

Author： Soleilhac Emmanuelle   Nadon Robert   Lafanechere Laurence  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.2, 2010-02, pp. : 135-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional genomic and high-content screening for target discovery and deconvolution

By Heynen-Genel Susanne   Pache Lars   Chanda Sumit K   Rosen Jonathan  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-01 ,pp. : 955-968

Informa Healthcare

Access to resources Recommend Favorite

High-content screening in microfluidic devices

By Cheong Raymond   Paliwal Saurabh   Levchenko Andre  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 8, 2010-08 ,pp. : 715-720

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in high-throughput mutation screening

By Larsen Lars Allan   Christiansen Michael   Vuust Jens   Andersen Paal Skytt  

Pharmacogenomics, Vol. 2, Iss. 4, 2001-11 ,pp. : 387-399

Future Medicine

Access to resources Recommend Favorite

High-content siRNA screening for target identification and validation

By Krausz Eberhard   Korn Kerstin  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 551-564

Informa Healthcare

Access to resources Recommend Favorite

Cough: potential pharmacological developments

By Chung KF  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 955-963

Informa Healthcare

Access to resources Recommend Favorite